Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2102 is a non-protein coding gene producing a long intergenic non-coding RNA (lincRNA) transcript. LincRNAs are defined as RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes, are typically not translated into proteins, and often reside in the nucleus. They can regulate gene expression, chromatin architecture, and transcription through diverse mechanisms — including acting as enhancers, stabilizing transcripts, or recruiting protein cofactors. LINC02102 is one of many annotated human lincRNAs, but as of now, no unique functional, disease, or pharmacological attributes are attributed to this specific gene. Its aliases include CTD-2044J15.1 and LINC02102.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2102 (LINC02102).